Patents by Inventor Kurt Voegtli

Kurt Voegtli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
    Publication number: 20210269429
    Abstract: Anti-viral active agents, particularly the free base hemihydrate form of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, as well as methods for the manufacture thereof. Also the use of the above compound in the treatment of human herpes virus infections and in the preparation of pharmaceuticals comprising said compound.
    Type: Application
    Filed: April 2, 2021
    Publication date: September 2, 2021
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Yogeshwar BACHHAV, Wilfried SCHWAB, Alexander BIRKMANN, Kurt VOEGTLI
  • N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
    Patent number: 11021474
    Abstract: The present invention relates to the field of anti-viral active agents, particularly the free base hemihydrate form of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide as well as methods for the manufacture thereof. The present invention relates also to the use of the above compound in the treatment of human herpes virus infections and in the preparation of pharmaceuticals comprising said compound.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: June 1, 2021
    Assignee: AiCuris Anti-Infective Cures GmbH
    Inventors: Yogeshwar Bachhav, Wilfried Schwab, Alexander Birkmann, Kurt Voegtli
  • N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
    Publication number: 20200123145
    Abstract: The present invention relates to the field of anti-viral active agents, particularly the free base hemihydrate form of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide as well as methods for the manufacture thereof. The present invention relates also to the use of the above compound in the treatment of human herpes virus infections and in the preparation of pharmaceuticals comprising said compound.
    Type: Application
    Filed: November 28, 2017
    Publication date: April 23, 2020
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Yogeshwar BACHHAV, Wilfried SCHWAB, Alexander BIRKMANN, Kurt VOEGTLI
  • CRYSTALLINE N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N- METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE MONO MESYLATE MONOHYDRATE HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION RANGE AND A SPECIFIC SURFACE AREA RANGE FOR USE IN PHARMACEUTICAL FORMULATIONS
    Publication number: 20170348297
    Abstract: The present invention relates to the crystalline mono mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide in a definite particle size range, particle size distribution and a specific surface area range, which has demonstrated increased long term stability and release kinetics from pharmaceutical compositions, as well as to pharmaceutical compositions containing said crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having the afore-mentioned particle size range, particle size distribution and specific surface area range.
    Type: Application
    Filed: August 22, 2017
    Publication date: December 7, 2017
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Wilfried SCHWAB, Alexander BIRKMANN, Kerstin PAULUS, Kurt VÖGTLI, Dieter HAAG, Stephan MAAS, Kristian RUEPP
  • Sulfonic acid salts of heterocyclylamide-substituted imidazoles
    Patent number: 9133165
    Abstract: The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventing diseases, in particular for use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: September 15, 2015
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Wilfried Schwab, Guido Schiffer, Kurt Voegtli, Andreas Kyas, Gerd Osswald
  • SULFONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES
    Publication number: 20140315924
    Abstract: The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventing diseases, in particular for use as antiviral agents, in particular against cytomegaloviruses.
    Type: Application
    Filed: September 12, 2012
    Publication date: October 23, 2014
    Applicant: AICURIS GMBH & CO. KG
    Inventors: Wilfried Schwab, Guido Schiffer, Kurt Voegtli, Andreas Kyas, Gerd Osswald